Immunotherapy in non-small cell lung cancer: Past, present, and future directions

Many decades in the making, immunotherapy has demonstrated its ability to produce durable responses in several cancer types. In the last decade, immunotherapy has shown itself to be a viable therapeutic approach for non-small cell lung cancer (NSCLC). Several clinical trials have established the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Punekar, Salman R., Shum, Elaine, Grello, Cassandra Mia, Lau, Sally C., Velcheti, Vamsidhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382405/
https://www.ncbi.nlm.nih.gov/pubmed/35992832
http://dx.doi.org/10.3389/fonc.2022.877594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382405/
https://www.ncbi.nlm.nih.gov/pubmed/35992832
http://dx.doi.org/10.3389/fonc.2022.877594

Ejemplares similares